ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Recursos principais

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
AI Entrar Premium IconPremium Help Menu
Índice Bovespa
120.269,31
-0,67%
S&P 500
5.970,84
-1,11%
US Dollar vs BRL
6,2161
0,33%
Bitcoin
93.694,25
0,19%
Brent Oil
73,79
0,22%
As Melhores Corretoras Online
Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Opko Health Inc (OPK)

  7. Opko Health Inc (OPK) Notícias

OPK

Opko Health (OPK)

Opko Health Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:OPK
DataHoraFonteTítuloCódigoCompanhia
10/12/202410:00PR Newswire (US)NextPlat Gains e-Commerce Access to Over 340 Million Consumers with Launch on JD.Com, China's Largest Online RetailerNASDAQ:OPKOpko Health Inc
20/11/202423:36Edgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:OPKOpko Health Inc
20/11/202410:00GlobeNewswire Inc.OPKO Health to Participate in the Piper Sandler 36th Annual Healthcare ConferenceNASDAQ:OPKOpko Health Inc
18/11/202410:00PR Newswire (US)NextPlat to Showcase OPKO Healthcare Products at the 2024 China International Natural Health & Nutrition ExpoNASDAQ:OPKOpko Health Inc
14/11/202408:00PR Newswire (US)NextPlat Reports $49.8 Million in Consolidated Revenue for the Nine Months Ended September 30, 2024, Representing a 136% Increase Over 2023 ResultsNASDAQ:OPKOpko Health Inc
13/11/202418:30Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:OPKOpko Health Inc
08/11/202418:05GlobeNewswire Inc.Entera Bio Reports Q3 2024 Financial Results and Provides Business UpdatesNASDAQ:OPKOpko Health Inc
07/11/202418:12Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OPKOpko Health Inc
07/11/202418:05GlobeNewswire Inc.OPKO Health Reports Third Quarter 2024 Business Highlights and Financial ResultsNASDAQ:OPKOpko Health Inc
07/11/202410:00GlobeNewswire Inc.Aspira Women’s Health Expands Co-Marketing and Distribution Collaboration with BioReference® to Include OvaWatch®NASDAQ:OPKOpko Health Inc
29/10/202417:05GlobeNewswire Inc.OPKO Health to Report Third Quarter 2024 Financial Results on November 7, 2024NASDAQ:OPKOpko Health Inc
07/10/202409:00PR Newswire (US)NextPlat Secures Four-Year Extension of OPKO Healthcare E-Commerce Program in China and Agrees to the Expansion of the Program into JapanNASDAQ:OPKOpko Health Inc
07/10/202409:00GlobeNewswire Inc.ModeX Therapeutics Secures $35 Million BARDA Supplement to Develop COVID Multispecific Antibodies and $16 Million to Initiate Influenza ProgramNASDAQ:OPKOpko Health Inc
25/09/202409:30GlobeNewswire Inc.Entera Bio and OPKO Health Provide Update on PK/PD Results of Oral Oxyntomodulin (GLP-1/Glucagon) Peptide Tablet Candidate for Obesity and Metabolic DisordersNASDAQ:OPKOpko Health Inc
23/09/202409:00GlobeNewswire Inc.OPKO Health’s ModeX Therapeutics Appoints Dr. Giovanni Abbadessa as Chief Medical Officer as Pipeline Advances into Clinical DevelopmentNASDAQ:OPKOpko Health Inc
20/09/202415:56Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:OPKOpko Health Inc
16/09/202408:30PR Newswire (US)Labcorp Completes Acquisition of Select Assets of BioReference Health's Diagnostics Business from OPKO HealthNASDAQ:OPKOpko Health Inc
30/08/202418:01Edgar (US Regulatory)Form DEFR14A - Revised definitive proxy soliciting materialsNASDAQ:OPKOpko Health Inc
19/08/202418:23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OPKOpko Health Inc
09/08/202417:05GlobeNewswire Inc.Entera Bio Reports Q2 2024 Financial Results and Provides Business UpdatesNASDAQ:OPKOpko Health Inc
07/08/202417:12Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:OPKOpko Health Inc
07/08/202417:06GlobeNewswire Inc.OPKO Health Reports Second Quarter 2024 Business Highlights and Financial ResultsNASDAQ:OPKOpko Health Inc
01/08/202417:05GlobeNewswire Inc.OPKO Health to Report Second Quarter 2024 Financial Results on August 7, 2024NASDAQ:OPKOpko Health Inc
18/07/202409:00GlobeNewswire Inc.OPKO Health Announces $100 Million Share Repurchase ProgramNASDAQ:OPKOpko Health Inc
17/07/202417:14GlobeNewswire Inc.OPKO Health and HealthCare Royalty Enter into $250 Million Note Purchase Agreement Secured by NGENLA’s Profit Share PaymentsNASDAQ:OPKOpko Health Inc
02/07/202409:00PR Newswire (US)NextPlat Expands E-Commerce Program in China to Include Broad Retail Distribution and Adds Digital/Social Media Marketing Capabilities with New Marketing PartnerNASDAQ:OPKOpko Health Inc
31/05/202411:48GlobeNewswire Inc.OPKO Health to Participate in the Jefferies Global Healthcare ConferenceNASDAQ:OPKOpko Health Inc
07/05/202417:05GlobeNewswire Inc.OPKO Health Reports First Quarter 2024 Business Highlights and Financial ResultsNASDAQ:OPKOpko Health Inc
03/05/202409:00GlobeNewswire Inc.OPKO Health to Report First Quarter 2024 Financial Results on May 7, 2024NASDAQ:OPKOpko Health Inc
28/03/202409:00PR Newswire (US)Labcorp Announces Acquisition of Select Assets of BioReference Health's Diagnostics BusinessNASDAQ:OPKOpko Health Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:OPK

Seu Histórico Recente

BOV
FICT3
Fictor Alimentos ON
BOV
TELB4
TELEBRAS PN
BOV
GFSA3
GAFISA ON
BOV
PDGR3
PDG REALT ON
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados